journal cover

Biological drug use: US perspectives on indications and monitoring

Annals of the Rheumatic Diseases

Oct 22, 2005

John J Cush

Abstract

An estimated 20% of patients with rheumatoid arthritis (RA) receive tumour necrosis factor (TNF) inhibitor treatment. This paper presents the results of an online survey of US rheumatologists (1023 respondents) conducted in April 2005 on issues relating to use of TNF inhibitors in RA. T...read more

Mentioned in this Paper

Prescribing Patterns, Physician
Antirheumatic Drugs, Disease-Modifying
Tumor Necrosis Factor-alpha
Tuberculosis
Enzymes, antithrombotic
Hepatic
Tumor Lysis Syndrome
Drug-induced Lupus Erythematosus
Selection of Subjects
Demyelinating Disease of Central Nervous System
Paper Details
References
  • References8
  • Citations35
1
  • References8
  • Citations35
1234

Similar Papers Found In These Feeds

Hereditary Demyelinating Diseases Of The CNS

Hereditary demyelinating diseases of the central nervous systems are caused primarily due to inherited genetic conditions. Examples include Alexander, Canavan, and Pelizaeus-Merzbacher diseases. Here is the latest research.

Tuberculosis

Tuberculosis is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. Discover the latest research on tuberculosis here.

Demyelinating Disorders of the CNS

Demyelinating diseases result in damage to the myelin sheath that surrounds nerves in the brain and spinal cord and can result in neurological conditions such as multiple sclerosis. Here is the latest research on demyelinating disorders of the central nervous system.

Central Nervous System Fungal Infections

Central nervous system fungal infections are rare and typically occur in immunocompromised patients, such as those with HIV infection or transplant recipients. Discover the latest research on central nervous system fungal infections here.

Drug-Induced Diseases

Drug-induced diseases (DID) also called as iatrogenic diseases. Most of these DIDs are largely preventable, if strict vigilance and proper periodic clinical and diagnostic monitoring are undertaken

© 2020 Meta ULC. All rights reserved

Biological drug use: US perspectives on indications and monitoring

Annals of the Rheumatic Diseases

Oct 22, 2005

John J Cush

PMID: 16239379

DOI: 10.1136/ard.2005.042549

Abstract

An estimated 20% of patients with rheumatoid arthritis (RA) receive tumour necrosis factor (TNF) inhibitor treatment. This paper presents the results of an online survey of US rheumatologists (1023 respondents) conducted in April 2005 on issues relating to use of TNF inhibitors in RA. T...read more

Mentioned in this Paper

Prescribing Patterns, Physician
Antirheumatic Drugs, Disease-Modifying
Tumor Necrosis Factor-alpha
Tuberculosis
Enzymes, antithrombotic
Hepatic
Tumor Lysis Syndrome
Drug-induced Lupus Erythematosus
Selection of Subjects
Demyelinating Disease of Central Nervous System

Similar Papers Found In These Feeds

Hereditary Demyelinating Diseases Of The CNS

Hereditary demyelinating diseases of the central nervous systems are caused primarily due to inherited genetic conditions. Examples include Alexander, Canavan, and Pelizaeus-Merzbacher diseases. Here is the latest research.

Tuberculosis

Tuberculosis is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. Discover the latest research on tuberculosis here.

Related Papers

Paper Details
References
  • References8
  • Citations35
1
  • References8
  • Citations35
1234
/papers/biological-drug-use-us-perspectives-on/16239379